Perplexity expands presence at 841-853 Broadway

Manhattan, NY The Feil Organization said that Perplexity has expanded its presence at 841-853 Broadway, bringing its total occupancy to 22,000 s/f across the two adjoining properties. Perplexity, which signed a lease for the entire fourth floor at 853 Broadway in June, has signed a new lease for the full fourth floor at 841 Broadway, also known as the Roosevelt Building. As part of the expansion, Feil will remove the wall dividing the two properties, creating a highly unique contiguous office space spanning both fourth floors.

“Perplexity’s expansion across 841–853 Broadway speaks to the kind of neighborhoods AI companies want to be part of today,” said Andrew Wiener, head of commercial leasing at The Feil Organization. “By delivering a one-of-a-kind space, we were able to provide a tailored solution that supports the way their team collaborates while reinforcing our ability to cater to the individual needs of all our tenants.” 

“We’ve enjoyed being part of the Union Square neighborhood, and as our team continues to expand, it was important for us to stay in the same area,” said Nathan Barksdale, general counsel and VP of operations at Perplexity. “The connected space gives us the visibility and flexibility we were looking for, and we’re excited to see how it sparks creativity and collaboration among our staff.”

841–853 Broadway is located at the intersection of the city’s business, retail, and entertainment districts, offering a highly connected setting that continues to attract high-growth, mission-driven tenants. 853 Broadway is a 21-story, 157,000 s/f office tower, while 841 Broadway, also known as the Roosevelt Building, is an eight-story, 91,300 s/f office property. Together, the buildings offer a rare combination of modern office space and immediate access to the Union Square transit hub.

The Feil Organization was represented in-house byWiener, Robert Fisher and Henry Korzec. Perplexity was represented by Marcella LaHara, Derek Feinman and Adam Spector of Newmark.